Discover undervalued stocks with Eulerpool.

Subscribe for $2

Thermo Fisher Scientific Stock TMO

Price

0
Today +/-
-0
Today %
-0 %

Thermo Fisher Scientific stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Thermo Fisher Scientific stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Thermo Fisher Scientific stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Thermo Fisher Scientific stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Thermo Fisher Scientific's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Thermo Fisher Scientific Stock Price History

DateThermo Fisher Scientific Price
9/24/20250 undefined
9/24/2025466.03 undefined
9/23/2025469.76 undefined
9/22/2025475.00 undefined
9/19/2025479.59 undefined
9/18/2025481.11 undefined
9/17/2025472.65 undefined
9/16/2025480.75 undefined
9/15/2025474.47 undefined
9/12/2025479.47 undefined
9/11/2025491.42 undefined
9/10/2025476.55 undefined
9/9/2025482.42 undefined
9/8/2025487.66 undefined
9/5/2025492.61 undefined
9/4/2025492.01 undefined
9/3/2025484.56 undefined
9/2/2025487.54 undefined
8/29/2025492.73 undefined
8/28/2025489.75 undefined
8/27/2025488.13 undefined
8/26/2025488.49 undefined

Thermo Fisher Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Thermo Fisher Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Thermo Fisher Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Thermo Fisher Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Thermo Fisher Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Thermo Fisher Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Thermo Fisher Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Thermo Fisher Scientific’s growth potential.

Thermo Fisher Scientific Revenue, EBIT and net profit per share

DateThermo Fisher Scientific RevenueThermo Fisher Scientific EBITThermo Fisher Scientific Net Income
2029e53.98 B undefined13.36 B undefined13.1 B undefined
2028e51.7 B undefined12.6 B undefined11.68 B undefined
2027e49.2 B undefined13.29 B undefined10.41 B undefined
2026e46.49 B undefined10.71 B undefined9.42 B undefined
2025e44.37 B undefined10 B undefined8.71 B undefined
202442.88 B undefined7.72 B undefined6.34 B undefined
202342.86 B undefined7.32 B undefined6 B undefined
202244.92 B undefined8.51 B undefined6.95 B undefined
202139.21 B undefined10.37 B undefined7.73 B undefined
202032.22 B undefined7.87 B undefined6.38 B undefined
201925.54 B undefined4.24 B undefined3.7 B undefined
201824.36 B undefined3.86 B undefined2.94 B undefined
201720.92 B undefined3.14 B undefined2.23 B undefined
201618.27 B undefined2.74 B undefined2.02 B undefined
201516.97 B undefined2.5 B undefined1.98 B undefined
201416.89 B undefined2.04 B undefined1.89 B undefined
201313.09 B undefined1.76 B undefined1.27 B undefined
201212.51 B undefined1.56 B undefined1.18 B undefined
201111.56 B undefined1.35 B undefined1.33 B undefined
201010.39 B undefined1.25 B undefined1.02 B undefined
20099.91 B undefined1.06 B undefined849.7 M undefined
200810.5 B undefined1.26 B undefined979.4 M undefined
20079.75 B undefined1.02 B undefined747.9 M undefined
20063.79 B undefined287.71 M undefined168.9 M undefined
20052.63 B undefined280.39 M undefined223.22 M undefined

Thermo Fisher Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (B)
NET INCOME (B)
NET INCOME GROWTH (%)
DIV. ()
DIV. GROWTH (%)
SHARES (M)
DOCUMENTS
1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e
0.190.240.280.330.380.540.620.720.810.951.351.732.272.931.981.882.292.282.191.851.92.212.633.799.7510.59.9110.3911.5612.5113.0916.8916.9718.2720.9224.3625.5432.2239.2144.9242.8642.8844.3746.4949.251.753.98
-24.2117.8019.0615.7139.6916.2615.7611.8117.7642.8327.7031.2929.16-32.50-5.0022.02-0.61-4.04-15.492.7016.1719.3643.98157.087.72-5.594.8611.218.234.6429.020.457.7214.4716.454.8626.1421.7114.55-4.580.053.474.795.825.084.41
37.8932.2034.5331.1232.9033.0831.8335.4233.6635.7644.2446.2745.3743.4546.5446.3845.6844.7843.7845.8646.2945.9745.3541.3639.0340.0639.3241.0041.4842.3342.2444.3645.7145.8045.1544.5844.3549.6250.0842.2439.9042.1240.7138.8536.7134.9333.46
0.070.080.10.10.130.180.20.260.270.340.60.81.031.270.920.871.051.020.960.850.881.011.191.573.84.213.94.264.795.35.537.497.768.379.4510.8611.3315.9919.6418.9717.118.0600000
00.010.010.010.020.020.030.030.050.060.080.10.140.190.240.18-0.17-0.0400.310.20.360.220.170.750.980.851.021.331.181.271.891.982.022.232.943.76.387.736.9566.348.719.4210.4111.6813.1
--50.0055.5628.5722.2218.1830.7738.2425.5328.8136.8433.6536.6925.79-24.27-196.13-79.31---35.2880.50-38.23-24.66344.6431.06-13.2820.3830.04-11.448.1648.784.282.3310.0932.0425.8072.4821.18-10.03-13.745.6737.478.2110.4512.2312.10
-----------------------------0.540.600.600.600.600.600.680.760.881.041.201.401.561.721.491.661.872.08
00000000000000000000000000000011.11000013.3311.7615.7918.1815.3816.6711.4310.26-13.3711.4112.6511.23
4546.6757.5260.7568.8574.9679.7183.2393.85106.12130.62151.23158.56175.61176.08162.97158.22170.52183.92186.61170.73167.64165.33203.7443.6434.7422.8409.4384.8366.6365.8402.3401.9397.439840640339939739438838300000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Thermo Fisher Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Thermo Fisher Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (B)
RECEIVABLES (B)
OTHER REC. (M)
INVENTORIES (B)
OTHER CURRENT LIAB. (B)
CURRENT ASSETS (B)
TANGIBLE ASSETS (B)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (B)
GOODWILL (B)
OTHER NON-CURRENT ASSETS (B)
NON-CURRENT ASSETS (B)
TOTAL ASSETS (B)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (B)
RETAINED EARNINGS (B)
OTHER EQUITY (B)
UNREAL. GAINS/LOSSES (M)
EQUITY (B)
LIABILITIES (B)
PROVISIONS (B)
OTHER SHORT-TERM LIAB. (B)
SHORT-TERM DEBTS (B)
LONG-TERM DEBT PORTION (B)
SHORT-TERM REC. (B)
LONG-T. LIAB. (B)
DEFERRED TAXES (B)
OTHER LIAB. (B)
LONG-T. LIABILITIES (B)
DEBT (B)
TOTAL CAPITAL (B)
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                                   
0.020.010.030.060.140.140.210.180.420.370.711.061.851.521.330.791.031.040.880.420.510.290.690.641.291.570.931.020.815.831.370.470.81.352.132.4410.354.488.528.085.57
0.040.060.070.080.10.130.150.180.20.230.30.410.570.690.870.50.550.450.410.430.420.470.571.391.451.481.411.471.761.81.942.472.543.053.884.144.956.478.959.439.668.19
000000000000000000000000000000000378.34320000000
0.030.030.030.040.050.060.080.120.120.170.190.230.330.430.540.330.370.390.340.330.30.340.361.161.171.171.131.171.331.441.491.861.992.212.973.013.374.035.055.635.094.98
00000.0100.010.020.020.060.050.070.10.160.160.770.650.590.180.130.260.150.130.410.410.410.420.560.710.780.610.830.740.580.791.351.141.11.641.641.763.4
0.090.10.130.190.30.330.450.50.760.831.241.712.063.133.092.932.362.471.971.771.41.471.353.663.674.354.534.144.824.839.886.545.747.029.4210.6311.8921.9620.1125.2324.5922.14
0.050.040.040.050.050.060.080.140.180.490.610.620.720.70.790.530.320.290.270.270.250.260.281.261.271.281.331.361.611.731.772.432.452.584.054.175.456.699.8610.87119.31
000000017.7525.8944.543.6362.4585.6694.463.3148.166.1517.119.3600000000000000000002255120
000000000000000000000000000000000000000740
000000000000000000000.070.160.457.517.166.426.345.917.827.87.0714.1112.7613.9716.6814.9814.0112.6920.1117.4416.6715.53
0.030.030.030.040.040.060.070.180.180.360.470.580.831.081.691.121.221.381.351.421.441.511.978.528.718.688.98911.9712.4712.518.8418.8321.3325.2925.3525.7126.0441.9241.244.0245.85
0.020.020.020.020.030.030.060.070.050.090.10.090.10.130.160.791.160.720.230.190.240.170.20.310.40.370.440.940.610.60.640.931.061.011.231.121.311.683.092.352.434.49
0.090.090.090.110.130.160.210.410.440.991.231.351.732.012.72.492.712.41.861.881.992.112.917.617.5416.7417.0917.2122.0122.6121.9836.3135.0938.8947.2545.6146.4947.175.0171.9374.1475.18
0.180.190.220.310.430.490.660.91.21.822.473.063.795.145.85.425.074.863.833.653.393.584.2521.2621.2121.0921.6321.3526.8327.4431.8642.8540.8345.9156.6756.2358.3869.0595.1297.1598.7397.32
                                                                                   
76.619.9217.517.7717.819.6921.8825.8627.147.9553.5689.01150159.21166.97167.43195.88199.82169.95175.48179.82181.82424.24439.3421.8423.9401.8406.4413.5369.6408.5411.9415.14284324344374394414420
0.040.040.040.060.070.070.070.110.230.260.470.490.610.80.841.031.051.681.761.211.31.381.4211.8112.2811.311.1410.0210.1510.58.2211.4711.812.1414.1814.6215.0615.5816.1716.7417.290
0.040.050.060.070.090.110.140.180.230.290.360.470.60.81.031.221.041.010.510.821.021.381.61.772.533.54.355.396.727.78.7510.4112.1413.9315.9118.722.0928.1235.4341.9147.360
-0-0-0-0.01-0-0.01-0.010-0-0.01-0.02-0.0100.01-0.04-0.01-0.07-0.11-0.1-0.040.080.160.020.150.39-0.150.090.04-0.4-0.16-0.08-1.29-2-2.64-2-2.5-2.68-2.81-2.33-3.1-3.2249.55
00000000000000007.211.76000000000007.71.31.31.80.9-10000000
0.090.090.10.150.170.190.230.310.480.560.861.011.311.7522.412.22.782.372.162.573.13.2314.1615.6515.0816.0115.8516.8818.4617.272122.3623.8528.5231.2534.9141.3349.725661.8749.55
0.010.020.020.030.030.060.060.070.060.070.090.120.170.20.250.120.140.140.110.110.10.130.150.630.680.540.530.550.610.640.690.820.820.931.431.621.922.182.873.382.870
0.020.020.020.030.030.040.070.160.220.220.270.310.40.490.550.30.390.320.360.310.280.240.290.860.880.820.820.91.041.161.251.831.722.022.752.442.674.15.385.454.840
0.010.010.010.010.020.010.010.020.020.020.020.040.050.060.110.240.270.160.140.20.250.190.210.180.190.170.170.160.190.20.20.480.560.660.730.830.931.42.662.62.6911.12
0000000000000000.060.110.080.060.370.04000000000000000002.520.3100
0.010.010.0100.010.010.030.0100.020.050.090.110.150.180.040.160.020.470.120.010.020.130.480.150.010.120.111.270.090.992.211.051.262.141.270.682.630.025.273.612.21
0.040.060.060.080.10.120.170.260.30.330.420.560.740.911.090.761.070.731.141.10.680.580.792.151.91.541.641.713.112.093.135.354.154.877.056.156.210.313.4417.0114.0113.33
0.050.040.050.060.130.150.180.210.250.490.651.051.121.551.741.811.571.530.730.450.230.230.472.182.052.032.072.035.767.039.512.3511.4215.3718.8717.7217.0819.1132.3328.9131.3129.06
000000000000000.090.090.020.010.010.010.010.020.072.562.281.991.931.632.232.051.613.432.622.562.772.272.191.793.842.851.920
0.010.010.010.010.010.010.040.040.040.280.270.120.150.240.150.110.050.040.030.060.080.090.130.460.490.60.560.620.70.810.771.171.31.572.572.523.243.344.544.244.645.26
0.060.050.060.070.140.160.210.250.30.770.921.171.271.791.9921.641.580.770.520.320.330.675.24.824.624.554.288.689.8911.8816.9515.3419.524.2122.522.5124.2440.713637.8734.32
0.10.110.110.140.240.290.380.510.61.11.341.7322.73.082.772.712.31.911.621.010.911.467.356.726.166.195.9911.811.9815.0122.319.4824.3731.2628.6528.7134.5554.1553.0151.8847.65
0.190.20.220.290.410.470.610.821.081.662.22.743.324.465.085.174.915.084.283.783.584.014.6921.5122.3621.2422.221.8428.6730.4432.2843.3141.8448.2159.7759.963.6275.87103.86109113.7597.2
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Thermo Fisher Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Thermo Fisher Scientific's financial health and stability.

Assets

Thermo Fisher Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Thermo Fisher Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Thermo Fisher Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Thermo Fisher Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)
DEPRECIATION (B)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (B)
PAID INTEREST (B)
PAID TAXES (B)
NET CASH FLOW FROM OPERATING ACTIVITIES (B)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (B)
NET CHANGE IN EQUITY (B)
CASH FLOW FROM FINANCING ACTIVITIES (B)
CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (B)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
19861987198819891990199119921993null19941995199619971998null1999nullnull200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.010.020.020.030.040.050.060.080.080.10.140.190.240.180.24-0.170.18-0.17-0.0400.310.20.360.220.170.750.980.851.041.331.181.271.891.982.022.232.943.76.387.736.965.96
0.010.010.010.010.020.020.030.040.040.070.090.120.140.080.140.090.160.110.10.10.040.050.070.120.240.760.790.760.740.860.9811.681.691.762.032.272.282.332.593.383.41
-404-2001214139420101-282-61-39-1622-173-5-73-98-131-243-266-123-301-472-621-524-620-1,098-379-302-552-647-995-1,300
0-1-2015-21-17-43-52-248-47-98-11538-1155-49-8-439-518-29-30-99-24-317115-162-265-34120167-436-178494-570-665-395-1,548-1,049-537
-0.01-0.01-0-0-0.01-0.01-00.020.0200.02-00.010.030.010.440.030.470.090.09-0.22-0.02-0.14-0.040.170.10.150.240.23-0.030.290.18-0.390.240.410.510.470.150.731.421.161.16
00.010.010.010.010.020.020.030.030.050.070.090.10.080.10.090.090.070.080.060.050.020.010.020.040.140.130.10.080.120.230.220.440.4400.530.690.790.470.560.671.39
000.010.010.010.020.020.010.010.030.050.090.150.090.150.070.120.070.090.040.060.030.040.090.120.120.290.310.370.50.290.230.590.4800.480.590.91.322.181.231.48
0.010.020.010.050.020.040.050.10.130.190.20.220.270.330.270.340.330.340.070.180.110.210.260.270.411.481.421.661.51.692.042.012.622.823.264.014.544.978.299.319.158.41
-9-10-21-27-24-33-60-62-56-65-64-124-111-38-111-61-148-87-74-84-41-41-50-43-76-175-264-200-245-260-315-282-427-422-444-508-758-926-1,474-2,523-2,243-1,479
-57-80-35-102-78-294-410-405-399-455-384-1,311-319-632-319-73-632-7322917446330834-753283-586-450-829-858-5,142-1,370-263-11,782-1,087-5,520-7,729-1,253-1,487-1,510-21,932-2,159-5,142
-48-69-13-74-53-261-350-342-342-390-320-1,186-208-594-208-12-4841330325850435084-709360-410-185-629-613-4,881-1,05519-11,355-664-5,076-7,221-495-561-36-19,40984-3,663
000000000000000000000000000000000000000000
0.050.080.030.070.020.220.360.120.090.360.190.880.390.360.3900.29-0.03-0.17-0.06-0.26-0.64-0.010.37-0.16-0.47-0.15-0.2-0.374.710.13.351.88-1.934.173.03-1.56-1.412.758.910.65-0.16
0.01-0-0.020.010.050.050.060.320.32-0.040.070.16-0.15-0.06-0.15-0.18-0.18-0.180.01-0.44-0.31-0.01-0.170.03-0.12-0.55-0.1-0.36-0.94-1.18-0.90.143.1-0.38-1.161.07-0.36-1.35-1.3-1.84-3-3
0.060.080.010.090.080.270.420.440.410.320.261.040.240.10.24-0.290.1-0.29-0.14-0.7-0.59-0.66-0.180.39-0.26-0.93-0.23-0.56-1.33.55-0.923.314.8-2.492.763.85-2.24-3.120.966.58-2.81-3.62
0000-1003010-1-4-200-4-113-5-8413-194-16-110-21796252122018305758-14-3-51-69-147-91-956
000000000000000000000000000000-142-216-234-240-238-237-266-297-337-395-455-523
0.010.02-0.010.040.020.010.060.130.140.060.08-0.050.18-0.20.18-0.04-0.2-0.040.15-0.34-0-0.110.13-0.110.45-0.040.660.28-0.650.1-0.215.02-4.48-0.890.350.550.760.317.91-5.854.05-0.44
3.59.8-7.924.4-2.95.9-5.138.60127135.1100157.4290.20275.900-4.89865.4173214.5227.4328.91,3081,155.81,459.21,252.41,430.11,724.41,728.32,1922,3942,8143,4973,7854,0476,8156,7896,9116,927
000000000000000000000000000000000000000000

Thermo Fisher Scientific stock margins

The Thermo Fisher Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Thermo Fisher Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Thermo Fisher Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Thermo Fisher Scientific's sales revenue. A higher gross margin percentage indicates that the Thermo Fisher Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Thermo Fisher Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Thermo Fisher Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Thermo Fisher Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Thermo Fisher Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Thermo Fisher Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Thermo Fisher Scientific Margin History

Thermo Fisher Scientific Gross marginThermo Fisher Scientific Profit marginThermo Fisher Scientific EBIT marginThermo Fisher Scientific Profit margin
2029e42.12 %24.75 %24.26 %
2028e42.12 %24.38 %22.6 %
2027e42.12 %27 %21.16 %
2026e42.12 %23.04 %20.27 %
2025e42.12 %22.54 %19.63 %
202442.12 %17.99 %14.77 %
202339.9 %17.08 %13.99 %
202242.24 %18.94 %15.47 %
202150.08 %26.44 %19.7 %
202049.62 %24.41 %19.79 %
201944.35 %16.62 %14.47 %
201844.58 %15.86 %12.06 %
201745.15 %15.03 %10.64 %
201645.8 %15.01 %11.06 %
201545.72 %14.72 %11.64 %
201444.36 %12.05 %11.22 %
201342.24 %13.45 %9.73 %
201242.33 %12.5 %9.42 %
201141.47 %11.66 %11.51 %
201041 %12.01 %9.84 %
200939.33 %10.72 %8.57 %
200840.07 %12.05 %9.33 %
200739.03 %10.43 %7.67 %
200641.36 %7.59 %4.45 %
200545.38 %10.65 %8.48 %

Thermo Fisher Scientific Stock Sales Revenue, EBIT, Earnings per Share

The Thermo Fisher Scientific earnings per share therefore indicates how much revenue Thermo Fisher Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermo Fisher Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermo Fisher Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermo Fisher Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermo Fisher Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermo Fisher Scientific Revenue, EBIT and net profit per share

DateThermo Fisher Scientific Sales per ShareThermo Fisher Scientific EBIT per shareThermo Fisher Scientific Earnings per Share
2029e140.94 undefined0 undefined34.2 undefined
2028e134.99 undefined0 undefined30.5 undefined
2027e128.46 undefined0 undefined27.18 undefined
2026e121.39 undefined0 undefined24.61 undefined
2025e115.85 undefined0 undefined22.74 undefined
2024111.96 undefined20.15 undefined16.54 undefined
2023110.46 undefined18.86 undefined15.45 undefined
2022114 undefined21.59 undefined17.64 undefined
202198.77 undefined26.12 undefined19.46 undefined
202080.75 undefined19.71 undefined15.98 undefined
201963.38 undefined10.53 undefined9.17 undefined
201860 undefined9.52 undefined7.24 undefined
201752.56 undefined7.9 undefined5.59 undefined
201645.98 undefined6.9 undefined5.09 undefined
201542.21 undefined6.21 undefined4.92 undefined
201441.98 undefined5.06 undefined4.71 undefined
201335.79 undefined4.81 undefined3.48 undefined
201234.12 undefined4.27 undefined3.21 undefined
201130.04 undefined3.5 undefined3.46 undefined
201025.39 undefined3.05 undefined2.5 undefined
200923.44 undefined2.51 undefined2.01 undefined
200824.15 undefined2.91 undefined2.25 undefined
200721.97 undefined2.29 undefined1.69 undefined
200618.61 undefined1.41 undefined0.83 undefined
200515.93 undefined1.7 undefined1.35 undefined

Thermo Fisher Scientific business model

Thermo Fisher Scientific Inc - A global market leader Thermo Fisher Scientific is one of the most popular companies on Eulerpool.com.

Thermo Fisher Scientific SWOT Analysis

Strengths

Thermo Fisher Scientific Inc offers a diverse portfolio of products, including scientific instruments, consumables, reagents, software, and services. This extensive range allows them to cater to the needs of various industries and customers, providing a strong competitive advantage.

Thermo Fisher Scientific Inc has established a strong brand reputation in the scientific research and healthcare sectors. Their commitment to innovation, quality, and reliability has earned the trust of customers worldwide, boosting their market position and customer loyalty.

Thermo Fisher Scientific Inc operates globally and has a well-established distribution network. Their wide geographic presence allows them to reach customers worldwide efficiently and effectively, contributing to their market share dominance and revenue growth.

Weaknesses

Thermo Fisher Scientific Inc heavily relies on continuous research and development activities for new product development and improvement. Any disruption or failure in R&D efforts could impact their ability to innovate and maintain a competitive edge in the market.

Thermo Fisher Scientific Inc operates in highly regulated industries, such as healthcare and pharmaceuticals. Changes in government regulations and policies can significantly impact their operations, requiring compliance adjustments that may incur additional costs or restrict market access.

Opportunities

The advancement of precision medicine presents an opportunity for Thermo Fisher Scientific Inc as it aligns with their expertise in genomics, proteomics, and other precision research areas. The increasing demand for personalized healthcare solutions can drive the adoption of their products and services.

Thermo Fisher Scientific Inc can capitalize on the rapid growth of emerging markets, such as Asia-Pacific and Latin America. By expanding their presence in these regions and adapting to local market needs, they can tap into new customer segments and boost their revenue streams.

Threats

Thermo Fisher Scientific Inc faces fierce competition from other global players and niche market entrants. The competitive landscape poses a threat to their market share, pricing power, and customer acquisition, necessitating consistent innovation, marketing, and strategic efforts to maintain their competitive position.

Fluctuations in the global economy, currency exchange rates, and geopolitical events can impact Thermo Fisher Scientific Inc's financial performance. Economic uncertainties, recessions, or downturns may reduce customer spending on scientific research and healthcare, affecting their sales and profitability.

Thermo Fisher Scientific Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermo Fisher Scientific Revenue by Segment

Segmente202320222021202020192018
Product--30.36 B USD25.31 B USD19.5 B USD18.87 B USD
Product revenues25.24 B USD28.55 B USD----
Service revenues17.61 B USD16.37 B USD----
Service--8.85 B USD6.91 B USD6.05 B USD5.49 B USD

  • 3 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermo Fisher Scientific Revenue by Segment

Segmente202320222021202020192018
Consumables17.6 B USD20.62 B USD22.61 B USD---
Instruments7.65 B USD7.92 B USD7.75 B USD---

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Thermo Fisher Scientific Revenue by Segment

Segmente202320222021202020192018
Consumables---18.53 B USD13.11 B USD12.58 B USD
Instruments---6.78 B USD6.39 B USD6.29 B USD

Thermo Fisher Scientific Revenue by Region

  • 3 years

  • 5 years

  • Max

Details
Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Thermo Fisher Scientific Revenue by Segment

DateAll Other CountriesAsia PacificAsia-PacificChinaEuropeGermanyJapanNorth AmericaOther CountriesOther regionsOther RegionsUnited KingdomUnited States
2023--7.87 B USD-10.74 B USD--22.76 B USD20.84 B USD1.48 B USD--22.01 B USD
2022--8.12 B USD3.79 B USD10.76 B USD--24.59 B USD17.3 B USD1.44 B USD--23.82 B USD
202116.86 B USD7.22 B USD-3.44 B USD11.13 B USD--19.66 B USD--1.2 B USD-18.91 B USD
202012.99 B USD5.82 B USD-2.8 B USD8.28 B USD--17.08 B USD--1.03 B USD-16.44 B USD
201910.42 B USD5.52 B USD-2.75 B USD6.36 B USD--12.9 B USD--764 M USD-12.37 B USD
201810.23 B USD5.25 B USD-2.5 B USD6.22 B USD--12.14 B USD--750 M USD-11.63 B USD
20178.68 B USD--2.06 B USD--------10.18 B USD
20164.98 B USD--1.73 B USD-995.8 M USD737.3 M USD----742.2 M USD9.09 B USD
20155.3 B USD--1.38 B USD-899.7 M USD-----778.1 M USD8.61 B USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Thermo Fisher Scientific Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Thermo Fisher Scientific historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Thermo Fisher Scientific shares outstanding

The number of shares was Thermo Fisher Scientific in 2024 — This indicates how many shares 383 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Thermo Fisher Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Thermo Fisher Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Thermo Fisher Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Thermo Fisher Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Thermo Fisher Scientific stock splits

In Thermo Fisher Scientific's history, there have been no stock splits.

Thermo Fisher Scientific dividend history and estimates

In 2024, Thermo Fisher Scientific paid a dividend amounting to 1.56 undefined. Dividend means that Thermo Fisher Scientific distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Thermo Fisher Scientific provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Thermo Fisher Scientific’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Thermo Fisher Scientific's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Thermo Fisher Scientific Dividend History

DateThermo Fisher Scientific Dividend
2029e2.08 undefined
2028e1.87 undefined
2027e1.66 undefined
2026e1.49 undefined
2025e0.43 undefined
2025e1.29 undefined
20241.56 undefined
20231.4 undefined
20221.2 undefined
20211.04 undefined
20200.88 undefined
20190.76 undefined
20180.68 undefined
20170.6 undefined
20160.6 undefined
20150.6 undefined
20140.6 undefined
20130.6 undefined
20120.54 undefined

Thermo Fisher Scientific dividend payout ratio

In 2024, Thermo Fisher Scientific had a payout ratio of 6.01%. The payout ratio indicates the percentage of the company's profits that Thermo Fisher Scientific distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Thermo Fisher Scientific represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Thermo Fisher Scientific could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Thermo Fisher Scientific's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Thermo Fisher Scientific Payout Ratio History

DateThermo Fisher Scientific Payout ratio
2029e6.09 %
2028e6.12 %
2027e6.1 %
2026e6.04 %
2025e6.23 %
20246.01 %
20235.88 %
20226.8 %
20215.34 %
20205.51 %
20198.27 %
20189.41 %
201710.73 %
201611.76 %
201512.17 %
201412.74 %
201317.14 %
201216.82 %
20115.88 %
20105.88 %
20095.88 %
20085.88 %
20075.88 %
20065.88 %
20055.88 %
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Thermo Fisher Scientific.

Thermo Fisher Scientific latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/20255.28 5.36  (1.61 %)2025 Q2
3/31/20255.15 5.15  (-0.07 %)2025 Q1
12/31/20246 6.1  (1.69 %)2024 Q4
9/30/20245.3 5.28  (-0.34 %)2024 Q3
6/30/20245.18 5.37  (3.75 %)2024 Q2
3/31/20244.76 5.11  (7.43 %)2024 Q1
12/31/20235.7 5.67  (-0.54 %)2023 Q4
9/30/20235.67 5.69  (0.43 %)2023 Q3
6/30/20235.48 5.15  (-6.02 %)2023 Q2
3/31/20235.08 5.03  (-0.92 %)2023 Q1
1
2
3
4
5
...
12

Eulerpool ESG Scorecard© for the Thermo Fisher Scientific stock

Eulerpool World ESG Rating (EESG©)

88/ 100

🌱 Environment

99

👫 Social

99

🏛️ Governance

65

Environment

Scope 1 - Direct Emissions
331,463
Scope 2 - Indirect emissions from purchased energy
427,904
Scope 3 - Indirect emissions within the value chain
11,320,351
Total CO₂ emissions
759,367
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees48
Percentage of women in management
Percentage of Asian employees14.76
Share of Asian management12.53
Percentage of Hispanic/Latino employees8.57
Hispano/Latino Management share5.94
Percentage of Black employees11.78
Black Management Share6.63
Percentage of white employees61.63
White Management Share72.22
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Thermo Fisher Scientific shareholders

%
Name
Stocks
Change
Date
8.77759 % The Vanguard Group, Inc.33,618,156304,6306/30/2025
4.42401 % BlackRock Institutional Trust Company, N.A.16,943,943-335,3286/30/2025
4.30312 % State Street Global Advisors (US)16,480,965-58,5246/30/2025
2.50093 % Capital World Investors9,578,573-1,482,8276/30/2025
2.11874 % Geode Capital Management, L.L.C.8,114,787-12,3996/30/2025
1.46417 % Morgan Stanley Smith Barney LLC5,607,7591,131,8766/30/2025
1.45830 % Norges Bank Investment Management (NBIM)5,585,297-469,2446/30/2025
1.41871 % Capital Research Global Investors5,433,659-2,179,1386/30/2025
1.40502 % JP Morgan Asset Management5,381,217-1,111,1196/30/2025
1.30510 % T. Rowe Price Associates, Inc.4,998,543-3,743,2346/30/2025
1
2
3
4
5
...
10

Thermo Fisher Scientific Executives and Management Board

Mr. Marc Casper

(56)
Thermo Fisher Scientific Chairman of the Board, President, Chief Executive Officer (since 2001)
Compensation 18.98 M

Mr. Michel Lagarde

(50)
Thermo Fisher Scientific Chief Operating Officer, Executive Vice President
Compensation 7.25 M

Mr. Stephen Williamson

(57)
Thermo Fisher Scientific Chief Financial Officer, Senior Vice President
Compensation 6.24 M

Mr. Gianluca Pettiti

(45)
Thermo Fisher Scientific Executive Vice President (since 2021)
Compensation 5.73 M

Mr. Michael Boxer

(62)
Thermo Fisher Scientific Senior Vice President, General Counsel
Compensation 3.12 M
1
2
3
4

Thermo Fisher Scientific Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Immuron Stock
Immuron
SupplierCustomer -0,46-0,460,33
NanoEnTek Stock
NanoEnTek
SupplierCustomer0,920,48-0,67-0,69-0,41
OraSure Technologies Stock
OraSure Technologies
SupplierCustomer0,880,850,540,700,060,34
Shenzhen Mindray Bio-Medical Electronics A Stock
Shenzhen Mindray Bio-Medical Electronics A
SupplierCustomer0,790,80-0,87-0,79-0,200,82
Evoke Pharma Stock
Evoke Pharma
SupplierCustomer0,760,47-0,61-0,60-0,420,19
Horizon Therapeutics Public Limited Company Stock
Horizon Therapeutics Public Limited Company
SupplierCustomer0,760,220,880,910,610,95
Quanterix Corporation Stock
Quanterix Corporation
SupplierCustomer0,71 -0,76-0,39-0,01
ACADIA Pharmaceuticals Inc. Stock
ACADIA Pharmaceuticals Inc.
SupplierCustomer0,71-0,32-0,93-0,65-0,37-0,46
Judges Scientific Stock
Judges Scientific
SupplierCustomer0,670,350,920,710,570,83
Xencor Stock
Xencor
SupplierCustomer0,670,51-0,20-0,75-0,530,44
1
2
3
4
5
...
13

Most common questions regarding Thermo Fisher Scientific

What values and corporate philosophy does Thermo Fisher Scientific represent?

Thermo Fisher Scientific Inc represents values centered on innovation, integrity, and customer focus. As a global leader in serving science, the company is committed to enabling their customers to make the world a healthier, cleaner, and safer place. Thermo Fisher Scientific Inc strives to provide cutting-edge technologies and solutions in the fields of life sciences, healthcare, and diagnostics. With a strong emphasis on research and development, their corporate philosophy aims to improve human health and wellbeing through constant innovation and collaboration with their customers. Thermo Fisher Scientific Inc is dedicated to delivering reliable and high-quality products and services that contribute to scientific advancements worldwide.

In which countries and regions is Thermo Fisher Scientific primarily present?

Thermo Fisher Scientific Inc is primarily present in multiple countries and regions worldwide. The company operates in North America, including the United States and Canada, where it has a strong presence. Additionally, Thermo Fisher Scientific Inc has a significant presence throughout Europe, with operations in countries such as the United Kingdom, Germany, France, and Spain. The company also serves customers in Asia, including China, India, Japan, and South Korea. Thermo Fisher Scientific Inc is expanding its footprint in emerging markets like Latin America and Africa, aiming to provide its products and services to customers globally.

What significant milestones has the company Thermo Fisher Scientific achieved?

Thermo Fisher Scientific Inc has achieved several significant milestones throughout its history. The company completed the acquisition of Life Technologies Corporation in 2014, which expanded its offerings in the life sciences field. Additionally, Thermo Fisher Scientific has made strides in advancing precision medicine and genetic research, developing innovative solutions for healthcare professionals. The company has also received recognition for its initiatives in sustainability, being included in the Dow Jones Sustainability World Index multiple times. Furthermore, Thermo Fisher Scientific has consistently reported robust financial performance, driving growth and shareholder value.

What is the history and background of the company Thermo Fisher Scientific?

Thermo Fisher Scientific Inc is a renowned company with a rich history and background. Established in 2006 through the merger of Thermo Electron and Fisher Scientific, it is now a global leader in serving the scientific research, pharmaceutical, and healthcare industries. With a diverse portfolio of innovative products and services, Thermo Fisher Scientific enables its customers to make important discoveries, enhance diagnostics, and improve overall patient care. The company's commitment to providing advanced solutions and expertise has propelled its growth, establishing it as a trusted partner in the scientific community. Today, Thermo Fisher Scientific continues to drive innovation and shape the future of scientific research and healthcare worldwide.

Who are the main competitors of Thermo Fisher Scientific in the market?

The main competitors of Thermo Fisher Scientific Inc in the market include Agilent Technologies, Danaher Corporation, and Illumina Inc.

In which industries is Thermo Fisher Scientific primarily active?

Thermo Fisher Scientific Inc is primarily active in the life sciences, healthcare, and research industries.

What is the business model of Thermo Fisher Scientific?

Thermo Fisher Scientific Inc is a renowned company that operates in the scientific research and healthcare sector. The business model of Thermo Fisher Scientific Inc centers around providing a wide range of products, services, and solutions to enable scientific discoveries and advancements. The company offers innovative instruments, consumables, software, and services to enable scientists and researchers to address complex challenges in various fields such as life sciences, pharmaceutical, biotechnology, and more. Thermo Fisher Scientific Inc also focuses on providing analytical instruments, reagents, consumables, software, and services to support healthcare professionals in diagnosing and treating various diseases. With its comprehensive offerings, Thermo Fisher Scientific Inc strives to empower its customers to make the world healthier, cleaner, and safer.

What is the P/E ratio of Thermo Fisher Scientific 2025?

The P/E ratio cannot be calculated for Thermo Fisher Scientific at the moment.

What is the P/S ratio of Thermo Fisher Scientific 2025?

The P/S cannot be calculated for Thermo Fisher Scientific currently.

What is the Quality Investing of Thermo Fisher Scientific?

The Quality Investing for Thermo Fisher Scientific is 5/10.

What is the revenue of Thermo Fisher Scientific 2025?

The expected Thermo Fisher Scientific revenue is 44.37 B USD.

How high is the profit of Thermo Fisher Scientific 2025?

The expected Thermo Fisher Scientific profit is 8.71 B USD.

What is the business model of Thermo Fisher Scientific

Thermo Fisher Scientific Inc is a global leading company in the field of laboratory analysis and diagnostic devices. The business model of Thermo Fisher Scientific Inc is based on providing solutions to businesses, government agencies, hospitals, research institutions, and many other customers. The company offers a variety of products and services in different business areas, including life sciences, diagnostics, analytics, and laboratory products. Thermo Fisher Scientific Inc has a strong presence in over 50 countries and serves customers in various industries and regions. Its wide range of products and services includes solutions for scientists and researchers in developing new drugs, improving healthcare, and protecting the environment. Additionally, the company offers diagnostic solutions for laboratories and physicians to enhance patient care, as well as specialized products and solutions for material analysis. Thermo Fisher Scientific Inc also provides a wide range of laboratory products and offers services such as system integration, validation, qualification, training, and support. With continuous research and development, acquisitions, and collaboration with customers, the company aims to expand and enhance its expertise in the field of science and technology.

What is the Thermo Fisher Scientific dividend?

Thermo Fisher Scientific pays a dividend of 1.2 USD distributed over 4 payouts per year.

How often does Thermo Fisher Scientific pay dividends?

Thermo Fisher Scientific pays out a dividend 4 times a year.

What is the Thermo Fisher Scientific ISIN?

The ISIN of Thermo Fisher Scientific is US8835561023.

What is the Thermo Fisher Scientific WKN?

The WKN of Thermo Fisher Scientific is 857209.

What is the Thermo Fisher Scientific ticker?

The ticker of Thermo Fisher Scientific is TMO.

How much dividend does Thermo Fisher Scientific pay?

Over the past 12 months, Thermo Fisher Scientific paid a dividend of 1.56 USD . This corresponds to a dividend yield of about . For the coming 12 months, Thermo Fisher Scientific is expected to pay a dividend of 1.49 USD.

What is the dividend yield of Thermo Fisher Scientific?

The current dividend yield of Thermo Fisher Scientific is .

When does Thermo Fisher Scientific pay dividends?

Thermo Fisher Scientific pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Thermo Fisher Scientific?

Thermo Fisher Scientific paid dividends every year for the past 18 years.

What is the dividend of Thermo Fisher Scientific?

For the upcoming 12 months, dividends amounting to 1.49 USD are expected. This corresponds to a dividend yield of 0.32 %.

In which sector is Thermo Fisher Scientific located?

Thermo Fisher Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Thermo Fisher Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Thermo Fisher Scientific from 10/15/2025 amounting to 0.43 USD, you needed to have the stock in your portfolio before the ex-date on 9/15/2025.

When did Thermo Fisher Scientific pay the last dividend?

The last dividend was paid out on 10/15/2025.

What was the dividend of Thermo Fisher Scientific in the year 2024?

In the year 2024, Thermo Fisher Scientific distributed 1.4 USD as dividends.

In which currency does Thermo Fisher Scientific pay out the dividend?

The dividends of Thermo Fisher Scientific are distributed in USD.

All fundamentals about Thermo Fisher Scientific

Our stock analysis for Thermo Fisher Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thermo Fisher Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.